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Background: The modified version of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ-M) is
used in patients with COPD to obtain information about their functional status. It consists of 3 components
(change in activities, dyspnea and fatigue) ranging from 0 to 100 and has been shown to be responsive following
pulmonary rehabilitation (PR). The interpretation of changes in PFSDQ-M score after an intervention is difficult in
the absence of the minimal important difference (MID) of the PFSDQ-M. This study aims at investigating the MID of
the PFSDQ-M.
Methods: We enrolled 301 patients with COPD (FEV1 42 ± 15%pred) that completed the PFSDQ-M before and after
a 3-month PR program (ΔChronic Respiratory Disease Questionnaire (CRDQ) +16 ± 12 points, ΔSix-minute walking
distance (6MWD) +47 ± 89 m, both p < 0.001). An anchor-based approach consisted of calculating the correlation
between the ΔPFSDQ-M and anchors with an established MID (ΔCRDQ and Δ6MWD). Linear regression analyses
were performed to predict the MID from these anchors. Secondly several distribution-based approaches
(Cohen’s effect size, empirical rule effect size and standard error of measurement method) were used.
Results: Anchor-based estimates for the different PFSDQ-M-components were between −3 and −5 points based on
CRDQ score and −6 (only calculated for change in activities) based on 6MWD. Using the distribution-based
methods, the estimates of MID ranged from −3 to −5 points for the different components.
Conclusions: We concluded that the estimate of MID of the PFSDQ-M after pulmonary rehabilitation corresponds
to a change of 5 points (range - 3 to −6) in each component in patients with severe COPD.
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Table 1 Baseline characteristics of the enrolled patients
Variables Mean ± SD Test-retest analyses
n = 301 n = 20
Gender (male/female) 241/60 15/5
Age (yrs) 65 ± 7 68 ± 6
BMI (kg/m2) 25 ± 5 27 ± 6
FEV1 (% pred) 42 ± 15 52 ± 11
FEV1/FVC (%) 39 ± 10 42 ± 9
GOLD stage (I/II/III/IV) 2/20/56/22 0/35/60/5
FRC (% pred) 156 ± 36 164 ± 37
TLC (% pred) 113 ± 18 124 ± 25
TL,CO (% pred) 47 ± 16 27 ± 6
PImax (% pred) 77 ± 26 75 ± 12
VO2 max (ml/kg/min) 14 ± 6 14 ± 4
W max (% pred) 64 ± 25 78 ± 20
6MWD (m) 396 ± 124 510 ± 85
PFSDQ-M activity (points) 47 ± 17 29 ± 18
PFSDQ-M dyspnea (points) 48 ± 17 28 ± 20
PFSDQ-M fatigue (points) 42 ± 19 24 ± 20
SD standard deviation, BMI body mass index, FEV1 forced expiratory volume in
one second, FVC forced vital capacity, GOLD Global Initiative on Obstructive
Lung Disease, FRC functional residual capacity, TLC total lung capacity, TLCO
transfer factor of carbon monoxide, PImax maximum inspiratory pressure,
6MWD, six minute walking distance, PFSDQ-M pulmonary functional status and
dyspnea questionnaire modified version.
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Patients suffering from chronic obstructive pulmonary
disease (COPD) have low spontaneous levels of daily
physical activity and impaired exercise performance [1].
They typically experience symptoms of dyspnea and
fatigue when performing activities of daily life (ADL).
Consequently, improving the patient’s functional status
and symptoms during ADL is an important goal for
treatment [1,2]. The modified Pulmonary Functional
Status and Dyspnea Questionnaire (PFSDQ) is an in-
strument designed to quantify the experienced change
in performing ADL compared with the period before
disease onset and symptoms of dyspnea and fatigue re-
lated to ADL [3]. The components of the PFSDQ-M are
assessed evaluating ten common activities, e.g. putting
on a shirt, walk on inclines and climbing three stairs. In
an era where patient-reported outcomes become in-
creasingly important [4], a questionnaire that specific-
ally evaluates the impact of the respiratory disease on
activities of daily life appears to be an interesting tool.
The magnitude of change after an intervention is diffi-
cult to interpret in the absence of the orientation on
what constitutes an important difference for this patient
reported outcome.
The minimal important difference (MID) of a specific
instrument can be defined as “the smallest difference in
score in the domain of interest which patients perceive
as beneficial and which would mandate, in the absence
of troublesome side effects and excessive cost, a change
in the patient’s management” [5]. Determination of the
MID is important for several reasons, as it facilitates
judging the magnitude of the benefit when comparing
two treatments, calculating sample sizes, making in-
ferences about the percentages of patients improved by a
therapeutic intervention (e.g. the number needed to
treat), and making cost effectiveness comparisons [6].
Although no golden standard exists in the approach to
calculate an MID, two global strategies have been pro-
posed [7]. The anchor-based approach uses the relation-
ship between the instrument under investigation and
independent measures that target the same concept. In
our situation, six-minute walking distance (6MWD) and
Chronic Respiratory Disease Questionnaire score where
used, as these anchors both evaluate aspects of activities
of daily life. The distribution-based method interprets
the magnitude of effect of the target instrument in rela-
tion to measures of variability.
The establishment of the MID for the PFSDQ-M
would add to the interpretation of the improvement of
dyspnea and fatigue symptoms and change in ADL after
a pulmonary rehabilitation (PR) program [8,9]. The
aim of this study was to establish the MID of the
PFSDQ-M in patients with COPD using an anchor and
distribution-based approach.Methods
Subjects
Four hundred and sixteen patients with a clinical diag-
nosis of COPD participated in the outpatient PR pro-
gram of the University Hospital Gasthuisberg in Leuven-
Belgium in the period from March 2000 to July 2010.
Patients were referred to the rehabilitation program with
a clinical indication for pulmonary rehabilitation (poor
exercise tolerance and disproportionate symptoms des-
pite optimal pharmacotherapy). Baseline assessment was
performed when patients were stable for at least four
weeks. Exceptionally, some individual patients have been
included earlier after the exacerbation based on advice
of the pulmonologist. One-hundred fifteen patients did
not complete the interviewed version of the PFSDQ-M
before and after the PR program and were excluded,
leaving a final sample 301 patients.
In addition, test-retest reliability was evaluated in 20
patients with COPD (FEV1 52 ± 11%pred; 6MWD 510 ±
85 m) using a one-week interval between assessments.
Baseline characteristics of both study samples are pro-
vided in Table 1.
The study protocol was approved by the ethics commit-
tee of University Hospital Gasthuisberg, Leuven (project
number B322201110245). Written informed consent was
obtained from all patients.
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Data were retrieved from the PR database of the hospital
where data at entry and follow up of PR were systema-
tically recorded. The patients followed a 3-month multi-
disciplinary program including three exercise training
sessions per week, according to international guidelines
[10,11]. Before and after the training program, patients
underwent an evaluation of lung function, respiratory
and peripheral muscle force, maximal exercise capacity,
6-min walk distance (6MWD), health-related quality of
life (CRDQ) and PFSDQ-M.
Measurements pre and post pulmonary rehabilitation
program
Static and dynamic lung volumes were measured
according to the European Respiratory Society guidelines
[12,13]. Diffusing capacity of the lung was assessed by
the single breath method [14]. Maximal inspiratory pres-
sure was measured from residual volume (MicroRPM;
CareFusion, Basingstoke, UK) and was compared with
reference values [15]. Functional exercise capacity was
assessed using the 6MWD test. The best of two standar-
dized tests was reported as percentage of the predicted
value [16]. Maximal exercise capacity was evaluated using
an incremental cycle ergometer (Ergometrics 900;
Ergoline, Bitz, Germany). After 2 min of resting breathing,
patients started a 3-min unloaded warm-up period. Subse-
quently work rate was increased by 10 W.min-1 until the
symptom limited peak work rate was reached [17]. Oxy-
gen uptake (VO2), carbon dioxide production (VCO2) and
ventilation were measured breath-by-breath and averaged
over 30 s (Vmax series; SensorMedics, Anaheim, CA,
USA). The CRDQ was used to assess health-related qual-
ity of life [18]. This 20-item questionnaire scores quality
of life in four domains (dyspnea, mastery, emotional func-
tioning and fatigue) and has been validated in the Dutch
language [19]. The total score can range from 20 to 140
with higher scores indicating better quality of life.
Assessment of pulmonary functional status and dyspnea
questionnaire – modified version
The PFSDQ-M consists of three components: dyspnea,
fatigue and change in activities experienced by patients
compared to the period before disease onset in 10 com-
mon activities [3]. The five general survey questions in
the dyspnea and fatigue component components are
considered informative and qualitative and these answers
are not further analyzed. For each component, each
activity is scored on an 11 point scale ranging from 0 to
10. Ratings on the dyspnea and fatigue component range
from 0 “No shortness of breath/fatigue” to 10 “Very se-
vere shortness of breath/fatigue” performing the specific
activities. The change component is also rated on an 11
point scale from 0 “As active as I’ve ever been” to 10,“Have omitted entirely (the activity)”. Dyspnea compo-
nent and fatigue component scores from 1–3 are labeled
as mild, scores from 4–6 moderate and scores from 7–9
severe symptoms. Change component scores from 1–3
are labeled as a minor change, 4–6 a moderate change
and 7–9 an extreme change in functional performance.
For each of the three components a score ranging from
0 to 100 is calculated with lower scores indicating a bet-
ter functional status. We also computed a total score
(sum of scores in the 3 components) to divide patients
in tertiles based on baseline functional status. The ques-
tionnaires were administered by the occupational therapist
of the multidisciplinary pulmonary rehabilitation program
as part of his baseline and follow-up assessment. It takes
10 to 15 minutes to complete the questionnaire.
Pulmonary rehabilitation program
Patients attended the rehabilitation program three times
per week. The multidisciplinary team consisted of a
pulmonologist, an occupational therapist, a dietician, a
psychologist, a social worker, a respiratory nurse and a team
of experienced physiotherapists. An intake with all these
professionals was scheduled at the start of the program
and follow-up visits were scheduled as deemed necessary.
Furthermore, all members of the team organized a group
education session. Training sessions consisted of high-
intensity aerobic training (treadmill walking, stationary
cycle training, stair climbing and arm ergometry) and re-
sistance training (upper and lower limbs). The session
duration varied from 45 to 90 minutes. Aerobic training
consisted of endurance training or interval training, when
endurance training at an adequate training intensity was
not feasible. Training intensity was increased gradually
throughout the program. A target Borg score of four
to six on perceived exertion or dyspnea was used to
ensure optimal training intensity. Oxygen therapy
was allowed during training to keep oxygen saturation
above 90%.
The short- and long-term effects of our multidisciplin-
ary rehabilitation program in terms of exercise tolerance
and health-related quality of life have been reported
previously [20].
Anchor and distribution based methods
Different methods were used to determine the MID of
the PFSDQ-M: one anchor-based method with two clin-
ical anchors related to functional status (CRDQ and the
6MWD) and three distribution-based methods (Cohen’s
effect size, empirical rule effect size and standard error
of measurement (SEM) method).
Anchor based method
Using linear regression analyses, the known MID of the
anchor was used to determine the corresponding
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components [21]. We used anchors that have been pre-
viously validated in patients with COPD: the CRDQ [22]
and the 6MWD [22-25].
The CRDQ is a widely used instrument in respiratory
rehabilitation used to assess health-related quality of life
[26]. The twenty-item questionnaire scores quality of life
in 4 domains which are dyspnea, fatigue, emotional
functioning and mastery [18]. A change of 0.5 per item
within each domain has been suggested as being the
MID of the CRDQ [6,27,28]. Therefore if all questions
within a domain are answered the clinically important
difference for each domain is as follows: dyspnea 2.5, fa-
tigue 2.0, emotional function 3.5 and mastery 2.0 points.
A change of 10 points in the total score for the CRDQ is
considered the MID. The interviewed Dutch version was
used in this study [19]. The dyspnea and fatigue domains
and the total score of the CRDQ were used as anchors.
The 6MWD is a standardized measure of functional
exercise capacity in patients with COPD [29]. The test
was performed in a 50 m long corridor of the hospital.
Standardized encouragement was provided. The best re-
sult of two tests on separate days was used for analysis
[16]. Changes in 6MWD are used to evaluate the efficacy
of therapeutic interventions such as pulmonary rehabi-
litation [23]. The minimal important difference of the
6MWD test in patients with COPD has already been de-
scribed in patients with different disease severity and using
varying methodology [22-25]. In the present study, we
opted to use the MID of 35 m, as proposed by Puhan et al.,
in our analysis [25]. This study investigated patients with
comparable disease severity and used valid techniques to
establish the MID, similar to our approach.
For the analyses we assessed the correlation between
changes in the anchors and changes in the PFSDQ-M com-
ponent scores. In addition, we used a linear regression ana-
lysis with PFSDQ-M component scores as the dependent
and the anchors as independent variables if correlation co-
efficients were ≥ 0.3[22]. Using the regression equation and
the MID of the anchors (0.5 points for each domain and 10Table 2 Baseline values, changes and correlations of changes
to 3-months rehabilitation program
N = 301
Baseline values ΔChanges from baseline
to 3-month PR
CRDQ dyspnea 15 ± 4 6 ± 5
CRDQ fatigue 15 ± 4 3 ± 3
CRDQ total 78 ± 16 16 ± 12
6MWD (m) 396 ± 124 47 ± 89
Data for changes are expressed in mean ± SD. SD standard deviation, PR pulmonary
questionnaire modified version, CRDQ chronic respiratory disease questionnaire, 6M
Pearson correlation coefficient, ‡p < 0.0001. *Values indicate sufficient correlation fopoints for total score in the CRDQ and 35 m for the
6MWD) we estimated the MID of PFSDQ-M component
scores.
Distribution based methods
We used the standard deviation (SD) of change in
PFSDQ-M score after the rehabilitation program to cal-
culate Cohen’s effect size and empirical rule effect size.
According to Cohen, 0.5 × SD units represent a moder-
ate effect size and investigators usually consider this esti-
mate to correspond to an important effect [30]. The
empirical rule effect size approach uses the empirical
rule that in a normal distribution 99% of all observations
lie within 3 SD below and above the mean. A change of
0.5 SD units corresponds to an 8% change within the
normal distribution. According to the empirical rule ef-
fect size approach, 8% of the observed range (from the
0.5th to the 99.5th percentile) corresponds to an import-
ant effect. The SEM method multiplies SD of the base-
line score with √ (1‐r), where r is the test-retest
reliability coefficient (intra-class correlation coefficient
(ICC)) of the PFSDQ-M [31].
Statistical analyses were performed with SAS 9. 2. V.2
statistical package.
Results
Baseline characteristics of 301 patients used to assess
the MID and 20 patients used to investigate test-retest
reliability are reported in Table 1.
Anchor-based approach
Table 2 shows baseline values and change after rehabi-
litation for PFSDQ-M and CRDQ scores and 6MWD.
Changes in PFSDQ-M scores were independent of age,
gender and baseline pulmonary function. The correlations
between changes in PFSDQ-M component scores and
changes in the anchors are also included in Table 2.
Figure 1 provides the distribution of the change in
PFSDQ-M dyspnea score after rehabilitation. Similar re-







- 6 ± 7 - 5 ± 7 - 5 ± 7
- 0.32*‡ - 0.30*‡ - 0.34*‡
- 0.27‡ - 0.23 ‡ - 0.21‡
- 0.42*‡ - 0.41*‡ - 0.41*‡
- 0.30*‡ - 0.26‡ - 0.27‡
rehabilitation, PFSDQ-M pulmonary functional status and dyspnea
WD six minute walking distance.
r using the anchor based method (linear regression analyses).
Figure 1 Frequency distribution of the change in PFSDQ-M
dyspnea score after a 3-month pulmonary rehabilitation program.
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established MID (0.5 point per item, and 10 points total
score, and 35 meters, respectively). Correlations ≥ 0.3 were
found between the change in PFSDQ-M components with
change in CRDQ dyspnea and total score. Only the
change in activity component of PFSDQ-M showed a
correlation ≥ 0.3 with change in 6MWD (Table 2). The re-
lationship between change in activity component scores
and change in the anchors (6MWD and CRDQ total
score) is illustrated in Figure 2. Correlations between
change in PFSDQ-M components and change in the
CRDQ fatigue domain were < 0.3. Table 3 shows the MID
(95% CI) estimates based on the anchor-based method.
The estimation of the MID was consistent across the
seven regression models (correlation ≥ 0.3) [22] and
ranged from −3.2 to −5.9 points. For the 6MWD Table 3
also provides the regression equation between PFSDQ-M
and the 6MWD as there are several proposed thresholds
for the MID of the 6MWD test. Using the regression
equation ΔPFSDQ-M= −(0.03 * Δ6MWD) - 5.06 the MID
of PFSDQ-M would be - 6,1 points using 35 m and −6.7
points using 54 m as MID of the 6MWD test. WhenFigure 2 Relationship between changes in activity domain score of P
scores (2B; r = −0.42, p < 0.001) after the rehabilitation program.applying the Cohen’s effect size method to our patient
group, our estimate of MID of the 6MWD test would be
44.5, which corresponds with an MID of −6.3 points for
the PFSDQ-M.
To investigate whether changes in PFSDQ-M were
influenced by the baseline functional status, we divided
patients in three tertiles based on baseline PFSDQ-M
total score (lower tertile: score ≤ 112; middle tertile:
112 < score < 162; higher tertile: ≥ 162) with the lower
tertile representing those patients with the best pre-
served functional status. Changes in PFSDQ-M per
tertile are shown in Figure 3 for the dyspnea component.
Similar graphs are obtained for the change in activities and
fatigue components. No significant differences in change of
PFSDQ-M components were found between tertiles.
Distribution-based approach
The ICC between test and retest was 0.79 for the change
in activity component and 0.77 for dyspnea and fatigue
components of PFSDQ-M. Table 4 shows the MID esti-
mates using the distribution-based methods Cohen’s
effect size, empirical rule effect size and SEM. The MID
of PFSDQ-M using these techniques ranged from – 3.1
to – 4.7 points.
Discussion
This is the first study to determine the minimal im-
portant difference of the modified version of the
PFSDQ in patients with severe COPD using different
approaches based on state-of-the-art analytic tech-
niques. Our estimates for the minimal important dif-
ference of the different PFSDQ-M components ranged
from −3 to −6 points with anchor-based methods
(using CRDQ dyspnea and total score and 6MWD as
anchors) and from −3 to −5 points using different
distribution-based methods (Cohen’s effect size, em-
pirical rule effect size and the standard error of mea-
surement method).
Anchor and distribution based method are concep-
tually very different [32]. Regardless of the apparentFSDQ-M and 6MWD (2A; r = −0.30, p < 0.001) and CRDQ total
Table 3 Anchor - based method to determine the minimal
important difference of the PFSDQ-M





(MID =0.5 per-item × 5 items)
−5.0 (−6 to −3) Activity
−4.0 (−5 to −2) Dyspnea
−3.2 (−4 to −1) Fatigue
CRDQ total score (MID = 10) −4.9 (−7 to −2) Activity
−4.0 (−6 to −1) Dyspnea
−3.3 (−5 to −1) Fatigue
6MWD (MID = 35 m) −6,1 (−7 to −5) Activity
MID minimal important difference, PFSDQ-M pulmonary functional status and
dyspnea questionnaire modified version, CRDQ chronic respiratory disease
questionnaire, 6MWD six minute walking distance.
Table 4 Distribution - based method to determine the
minimal important difference of the PFSDQ-M













MID minimal important difference, PFSDQ-M pulmonary functional status and
dyspnea questionnaire modified version.
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verse methods yield apparently similar findings [33,34].
Despite the low correlation found between changes in
the target instrument and changes of the anchors, the
consistency of the result using different techniques to es-
tablish the MID and our large sample size [23,35] support
the validity of our findings. As a consequence of the low
correlation coefficient (< 0.3) [22] between the instru-
ments we could not use the CRDQ fatigue domain as an
anchor, neither the 6MWD for the PFSDQ-M dyspnea
and fatigue component.
Estimates of the magnitude of clinically meaningful
change in physical performance measures can contribute
to the needs of clinical and research outcomes [35] of
interventions. Functional status assessment is anFigure 3 Box plots of change in the dyspnea component of
PFSDQ-M after 3 months of pulmonary rehabilitation related to
baseline functional status. Patients are divided in 3 tertiles based
on baseline total PFSDQ-M score (lower tertile: ≤ 112; 112 <middle
tertile < 162; higher tertile: ≥ 162 points; the lower tertile represents
those patients with the best preserved functional status). No
significant differences were observed between tertiles. Similar results
were obtained for change in activities and fatigue components
of PFSDQ-M.important aspect in evaluating the patient’s ability to
perform daily activities. The PFSDQ-M is a reliable and
valid questionnaire [3,22]. In addition, it has been shown
to be responsive to changes following pulmonary re-
habilitation [22] and based on our data changes are in-
dependent of baseline functional status.
We suggest that when a group of patients decrease
their PFSDQ-M score around 5 points this would be in-
dicative of a clinically significant improvement of func-
tional status. Estimations of the MID were similar in
subgroups of patients with different baseline functional
status. A change of −5 points corresponds approximately
to a 12% change from the baseline scores and 5% of the
range. This % of the range is in line with that observed
in other questionnaires (e.g. SGRQ; MID of 4 points cor-
responds with 4% of the range) [36]. Other studies using
other interventions may further fine tune the minimal
important difference of the PFSDQ-M.
The PFSDQ-M is an instrument used in pulmonary
rehabilitation that provides information about patient’s
symptoms and their functional performance [3]. The
meaningful change criteria of the PFSDQ-M appear
achievable, because it is comparable with the magni-
tudes of improvement reported in research studies
[37,38]. In addition, previous studies showed significant
improvement in functional status after 3-month re-
habilitation program [39,40], with decrease in PFSDQ-M
scores that are in line with our results.
The estimates of change should be considered as pre-
liminary evidence and will require further confirmation
using similar as well as additional techniques. Patient
ratings that could reflect perceived changes in exercise
capacity and functional performance have also been used
to identify minimal clinically important differences in
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be biased by poor recollection and particularly changes
in expectations when patients have to judge on them-
selves over a large period of time.
Limitations of the study
Although we introduced original and new findings, the
study has limitations which need to be addressed. First,
this is a retrospective study over a long time period
(eleven years). Although over this time period some
changes in staffing were inevitable, the composition of the
multidisciplinary team and the approach of the exercise
training and the assessments have been consistent. The
occupational therapist who administered the PFSDQ-M
questionnaires was the same person throughout the study
period. Second, the majority of included patients suffered
from severe COPD, which prevents from generalizing our
findings to all GOLD stages. Third, the Dutch version of
the PFSDQ-M has not been validated. Although it is gen-
erally a translation of the original English version, the
items brush hair and walk on bumpy terrain were replaced
by putting on socks and shopping to optimize content
validity. This adaptation was made with permission of the
developers of the PFSDQ-M questionnaire.
Clinical relevance
This study is the first to determine the MID of the modi-
fied version of the PFSDQ and provides a framework to
judge impact of rehabilitation interventions on this patient
reported outcome. Furthermore the established MID is a
potential tool for clinical rehabilitation programs to assess
efficacy of the program. It is however important to men-
tion that the MID is not designed to evaluate training
response in individual patients, due to the test-retest vari-
ability of the PFSDQ-M.
Conclusions
The minimal important difference of the PFSDQ-M corre-
sponds to a change of −5 points (range - 3 to −6 points) in
patients with severe COPD on a scale ranging from 0 to
100 in each component. This estimate was confirmed by
both anchor and distribution - based methods and seems
relatively stable across baseline functional status. The
PFSDQ-M is capable of capturing change in functional
status over time. Further studies are necessary to evaluate
whether the MID of PFSDQ-M remains stable in earlier
stages of COPD.
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